Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer agent

Abstract

Propranolol (PRO) is a well-known and widely used non-selective beta-adrenergic receptor antagonist (beta-blocker), with a range of actions which are of interest in an oncological context. PRO displays effects on cellular proliferation and invasion, on the immune system, on the angiogenic cascade, and on tumour cell sensitivity to existing treatments. Both… (More)

Topics

1 Figure or Table

Slides referencing similar topics